Pay in 4 interest-free payments of $6.57 Learn more
Ships within 48 hours · Estimated delivery Aug 6 - Aug 11
The Precision Peptide Genetic Test analyzes 49 peptides across 14 metabolic pathways to identify genetic variants affecting GLP-1 responsiveness, including GIPR rs1800437 and GLP1R rs6923761
Clinical trials are needed to confirm safety and dosing
In patients with chronic obstructive pulmonary disease (COPD), CLA supplementation at a dose of 3.2 g/day for 6 weeks (c9, t11, and c12, t10 isomers in a 50/50 ratio) demonstrated a reduction in serum oxidative stress-related factors, including MDA and matrix metalloproteinase-9 (MMP-9), compared to the placebo group [27], The study suggested that these antioxidant effects were likely a result of the anti-inflammatory properties of CLA, which partly occur through the stimulation of peroxisome proliferator-activated receptors [27]
Active infections: Peptide therapy during active infections is not recommended, as the immune-modulating effects could theoretically interfere with the body response to the infection
217 (7): p
![PDF] Effects Of GLP-1 Analogues, DPP-4 Inhibitors And SGLT2 Inhibitors On The Renal System](https://figures.semanticscholar.org/c15f0327b75d4570d8ee6263ce3f83d7e6f770a3/2-Table1-1.png)
